
PRECIGEN INC
Action · US74017N1054 · PGEN · A2PZG1 (XNAS)
1,50 USD
06.06.2025 17:51
Cours actuels de PRECIGEN INC
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NASDAQ |
PGEN
|
USD
|
06.06.2025 17:51
|
1,50 USD
| 1,33 USD
+12,41 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
10,05 % | 12,83 % | -1,64 % | -22,54 % | 93,40 % | -14,57 % | -53,43 % |
Profil de l'entreprise pour PRECIGEN INC Action
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Fonds investis
Les fonds suivants ont investi dans : PRECIGEN INC investi :
Fonds | Vol. en millions 42,33 | Part (%) 0,10 % |
Données de l'entreprise
Nom PRECIGEN INC
Société Precigen, Inc.
Symbole PGEN
Site web
https://www.precigen.com
Marché d'origine
NASDAQ

WKN A2PZG1
ISIN US74017N1054
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Helen Sabzevari MPH, Ph.D.
Capitalisation boursière 409 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 20374 Seneca Meadows Parkway, 20876 Germantown
Date d'introduction en bourse 2013-08-08
Changements d'identifiant
Date | De | À |
---|---|---|
03.02.2020 | XON | PGEN |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | I5X.F |
NASDAQ | PGEN |
Autres actions
Les investisseurs qui détiennent PRECIGEN INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.